February 20, 2018
Antitrust Associate Amanda Hamilton published an article in FDLI’s Update Magazine for the January-February 2018 Issue entitled “Navigating an FTC Drug Pricing Investigation.” The article provides insights into how the FTC handles drug pricing investigations, which can be a confusing process if you are unfamiliar with the FTC’s policies and practices.
We may be hearing more about FTC drug pricing investigations in the future. During the confirmation hearing before the Senate, Nominee for FTC Chairman, Joe Simons, said he would create a taskforce at the FTC to monitor drug pricing which may lead to additional drug pricing investigations. Haug Partners lawyers are available to assist in addressing any questions you have regarding an FTC drug pricing investigation. Please contact any member of the firm’s Antitrust practice group.
**This article is published here with permission from FDLI.
Hamilton, Amanda. “Navigating an FTC Drug Pricing Investigation.” FDLI, 20 Feb. 2018, www.fdli.org/2018/02/update-navigating-ftc-drug-pricing-investigation/.